WendellandCarolyn/iStock Editorial via Getty Images
Hooks (New York Stock Exchange:KR) has followed Costco Wholesale (NASDAQ:COST) by offering popular GLP-1 drugs such as Wegovy and Zepbound, developed by Novo Nordisk (NVO) and Eli Lilly (LLY), as part of a revamped weight management program.
In a statement on Friday, the company said eligible patients will be able to access weight-loss medications, including Wegovy and Zepbound, as part of the program, available at a starting price of $99 per visit.
Kroger Health's The Little Clinic unit, which operates about 226 clinics in nine states, is tasked with running the new program through in-person and telehealth visits.
In April, Costco (COST) also announced a new weight loss program to offer its members access to GLP-1 medications in partnership with healthcare marketplace Sesame. The renewable program launched with a three-month subscription fee of $179.
